Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (471-480 of 524) with videos related to

Pageof 53
Sort By:
Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Cancer Cell|October 15, 2021
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerJoseph M Chan, Álvaro Quintanal-Villalonga, Vianne Ran Gao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
COVID-19 in patients with lung cancerJ Luo, H Rizvi, I R Preeshagul, et al.
Cancer Cell|July 25, 2020
Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionNemanja Despot Marjanovic, Matan Hofree, Jason E Chan, et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Science Translational Medicine|August 28, 2015
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoLaura R Saunders, Alexander J Bankovich, Wade C Anderson, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Evolution of oncogene amplification across 86,000 cancer cell genomesJake June-Koo Lee, Sohrab Salehi, Matthew A Myers, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
International Journal of Cancer|November 5, 2011
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studiesBeate Pesch, Benjamin Kendzia, Per Gustavsson, et al.
Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.
Pageof 53

Showing results (471-480 of 524) with videos related to

Sort By:
Pageof 53
Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Cancer Cell|October 15, 2021
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerJoseph M Chan, Álvaro Quintanal-Villalonga, Vianne Ran Gao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
COVID-19 in patients with lung cancerJ Luo, H Rizvi, I R Preeshagul, et al.
Cancer Cell|July 25, 2020
Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionNemanja Despot Marjanovic, Matan Hofree, Jason E Chan, et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Science Translational Medicine|August 28, 2015
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoLaura R Saunders, Alexander J Bankovich, Wade C Anderson, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Evolution of oncogene amplification across 86,000 cancer cell genomesJake June-Koo Lee, Sohrab Salehi, Matthew A Myers, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
International Journal of Cancer|November 5, 2011
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studiesBeate Pesch, Benjamin Kendzia, Per Gustavsson, et al.
Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.
Pageof 53